OptiBiotix Health Plc (AIM:OPTI)
London flag London · Delayed Price · Currency is GBP · Price in GBX
10.70
-0.55 (-4.89%)
Jul 8, 2025, 3:07 PM GMT+1

OptiBiotix Health Company Description

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally.

The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits.

Its products include Slimbiome, which offers a scientifically supported, non-pharmaceutical approach to reduce hunger and cravings; CholBiome, a food supplement for reducing cholesterol and blood pressure and supporting vascular health; and Sweetbiotix which are dietary fibres used as an alternative to sugar and existing sweeteners.

The company also provides WellBiome a novel in vitro model of the human gut; OptiBiotics, a portfolio of prebiotics developed to target and enhance the growth of specific probiotics; and SlimBiome X3, a supplement that helps users cut calories without hunger and cravings.

The company was formerly known as Ducat Ventures PLC and changed its name to OptiBiotix Health Plc in August 2014.

OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.

OptiBiotix Health Plc
Country United Kingdom
Founded 2006
Industry Biotechnology
Sector Healthcare
Employees 10
CEO Stephen O'Hara

Contact Details

Address:
Innovation Centre
York, YO10 5DG
United Kingdom
Website optibiotix.com

Stock Details

Ticker Symbol OPTI
Exchange London Stock Exchange AIM
Fiscal Year January - December
Reporting Currency GBP
ISIN Number GB00BP0RTP38
SIC Code 2836

Key Executives

Name Position
Stephen O'Hara Chief Executive Officer
David Blain Chief Financial Officer
Paul Cannings Chief Operating Officer